Company Overview of Lifecore Biomedical, LLC
Lifecore Biomedical, LLC develops, manufactures, and markets advanced sodium hyaluronan based products. It offers pharmaceutical grade sodium hyaluronate produced by a microbial fermentation process and is used in various medical applications. The company’s products also include Corgel BioHydrogel, a biocompatible, patented hyaluronan hydrogel based on di-hydroxyphenyl linkages of tyramine substituted sodium hyaluronate; and oligosaccharides and Mw ladders for the academic and corporate research communities. It also offers design and development, contract fermentation and purification, and aseptic filling services. In addition, it offers clinical products, such as Lurocoat, a ophthalmic visc...
3515 Lyman Boulevard
Chaska, MN 55318
Founded in 1965
Key Executives for Lifecore Biomedical, LLC
Chairman of Landec Corp and Chief Executive Officer of Landec Corp
Chief Scientific Officer and Vice President
Vice President of New Business Development
Compensation as of Fiscal Year 2014.
Lifecore Biomedical, LLC Key Developments
Lifecore Reports Unaudited Earnings Results for the Fourth Quarter and Full Year Ended May 25, 2014; Provides Earnings Guidance for the Fiscal 2015
Jul 29 14
Lifecore reported unaudited earnings results for the fourth quarter and full year ended May 25, 2014. For the quarter, the company reported revenues of $8.165 million compared to $8.238 million a year ago. Net income was $0.526 million compared to $0.945 million a year ago.
For the year, the company reported revenues of $45.704 million compared to $41.281 million a year ago. Net income was $11.462 million compared to $9.414 million a year ago.
For fiscal 2015, the company expects revenues to be down 5% to 10% and operating income to be down 30% to 35% as a result of the one-time inventory reduction during fiscal 2015 by one of Lifecore's customers.
Lifecore Reports Earnings Results for the Fourth Quarter and Full Year Ended May 26, 2013; Provides Earnings Guidance for 2014
Jul 31 13
Lifecore reported earnings results for the fourth quarter and full year ended May 26, 2013. For the quarter, the company reported revenues of $8.238 million compared to $6.861 million a year ago. Net income was $0.945 million compared to $0.402 million a year ago.
For the year, the company reported revenues of $41.281 million compared to $34.283 million a year ago. Net income was $9.414 million compared to $7.672 million a year ago.
For fiscal 2014, the company expects that revenues will grow approximately 10% to 15% and pre-tax net income will grow approximately 20%.
Lifecore Biomedical, LLC Announces Resignation of Dennis J. Allingham as President and Chief Executive Officer
May 9 13
On May 6, 2013, Dennis J. Allingham tendered his resignation as president and chief executive officer of Lifecore Biomedical, LLC, and effective June 1, 2013.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|